AAAAAA

   
Results: 1-9 |
Results: 9
University of Washington high-dose cyclophosphamide, mitoxantrone, and etoposide experience in metastatic breast cancer: Unexpected cardiac toxicity
Authors: Gralow, JR Livingston, RB
Citation: Jr. Gralow et Rb. Livingston, University of Washington high-dose cyclophosphamide, mitoxantrone, and etoposide experience in metastatic breast cancer: Unexpected cardiac toxicity, J CL ONCOL, 19(18), 2001, pp. 3903-3904
(18)Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer
Authors: Eubank, WB Mankoff, DA Takasugi, J Vesselle, H Eary, JF Shanley, TJ Gralow, JR Charlop, A Ellis, GK Lindsley, KL Austin-Seymour, MM Funkhouser, CP Livingston, RB
Citation: Wb. Eubank et al., (18)Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer, J CL ONCOL, 19(15), 2001, pp. 3516-3523
[F-18]fluoroestradiol radiation dosimetry in human PET studies
Authors: Mankoff, DA Peterson, LM Tewson, TJ Link, JM Gralow, JR Graham, MM Krohn, KA
Citation: Da. Mankoff et al., [F-18]fluoroestradiol radiation dosimetry in human PET studies, J NUCL MED, 42(4), 2001, pp. 679-684
Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma
Authors: Daling, JR Malone, KE Doody, DR Johnson, LG Gralow, JR Porter, PL
Citation: Jr. Daling et al., Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma, CANCER, 92(4), 2001, pp. 720-729
Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-rise breast cancer
Authors: Bellon, JR Lindsley, KL Ellis, GK Gralow, JR Livingston, RB Seymour, MMA
Citation: Jr. Bellon et al., Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-rise breast cancer, INT J RAD O, 48(2), 2000, pp. 393-397
Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression
Authors: Bernhard, H Huseby, ES Hand, SL Lohmann, M Batten, WY Disis, ML Gralow, JR zum Buschenfelde, KHM Ohlen, C Cheever, MA
Citation: H. Bernhard et al., Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression, IMMUNOBIOL, 201(5), 2000, pp. 568-582
Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: High complete response rate in a phase I-II study of doxorubicin-treated patients
Authors: Ellis, GK Gralow, JR Pierce, HI Williams, MA Livingston, RB
Citation: Gk. Ellis et al., Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: High complete response rate in a phase I-II study of doxorubicin-treated patients, J CL ONCOL, 17(5), 1999, pp. 1407-1412
Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: Preliminary experience
Authors: Hathaway, PB Mankoff, DA Maravilla, KR Austin-Seymour, MM Ellis, GK Gralow, JR Cortese, AA Hayes, CE Moe, RE
Citation: Pb. Hathaway et al., Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: Preliminary experience, RADIOLOGY, 210(3), 1999, pp. 807-814
Monitoring the response of patients with locally advanced breast carcinomato neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography
Authors: Mankoff, DA Dunnwald, LK Gralow, JR Ellis, GK Drucker, MJ Livingston, RB
Citation: Da. Mankoff et al., Monitoring the response of patients with locally advanced breast carcinomato neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography, CANCER, 85(11), 1999, pp. 2410-2423
Risultati: 1-9 |